The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Immunocore Holdings plc ADR shares valued at $23,993,224 were purchased by BAKER BROS. ADVISORS LP on Mar 17 ’25. At $29.72 per share, BAKER BROS. ADVISORS LP acquired 807,338 shares. The insider’s holdings grew to 2,144,060 shares worth approximately $76.24 million following the completion of this transaction.
Also, Brian Di Donato purchased 100,000 shares, netting a total of over 3,000,000 in proceeds.
Before that, Brian Di Donato had added 56,250 shares to its account. In a trade valued at $1,638,511, the affiliate bought Immunocore Holdings plc ADR shares for $29.13 each.
As published in their initiating research note from Deutsche Bank on May 27, 2025, Immunocore Holdings plc ADR [IMCR] has been a Buy and the price target has been revised to $65. Analysts at Morgan Stanley downgraded the stock from ‘”an Overweight”‘ to ‘”an Equal-weight”‘ outlook in a report released in mid December. As of November 11, 2024, Mizuho has decreased its “an Outperform” rating to a “Neutral” for IMCR. Earlier on October 24, 2024, UBS initiated its rating. Their recommendation was “a Sell” for IMCR stock.
Analyzing IMCR Stock Performance
During the last five days, there has been a drop of approximately -5.68%. Over the course of the year, Immunocore Holdings plc ADR shares have jumped approximately 20.54%. Shares of the company reached a 52-week high of $39.33 on 06/04/25 and a 52-week low of $23.15 on 04/09/25.
Support And Resistance Levels for Immunocore Holdings plc ADR (IMCR)
According to the 24-hour chart, there is a support level at 35.01, which, if violated, would cause prices to drop to 34.47. In the upper region, resistance lies at 36.60. The next price resistance is at 37.65. RSI (Relative Strength Index) is 58.44 on the 14-day chart, showing neutral technical sentiment.
